BLEEDING RATE, FVIII UTILIZATION, CORTICOSTEROID USE, QUALITY OF LIFE AND SAFETY 4-YEARS AFTER GENE TRANSFER WITH VALOCTOCOGENE ROXAPARVOVEC IN A BRAZILIAN COHORT: RESULTS FROM GENER8-1 MC Ozelo; GGY Hayakawa; ANL Prezotti; MH Cerqueira; PR Villaça; C Lorenzatto; T Robinson;

LOW-DOSE IMMUNE TOLERANCE INDUCTION WITH EMICIZUMAB PROPHYLAXIS IN HEMOPHILIA A PATIENTS WITH HIGH-TITER INHIBITORS: PRELIMINARY RESULTS FROM THE BRAZILIAN EXPERIENCE C Costa-Lima; JO Frade-Guanaes; VB Faiotto; AP Francisco; NM Foschi; ALA Sambo; MMT Hosokawa; V Stahl; LGR Lima; B Stefanello; LW Santos; SS Medina; MP Colella; SAL Montalvão; GG Yamaguti-Hayakawa; MC Ozelo;

RESULTS FROM A 52-WEEK, NONINTERVENTIONAL STUDY OF BRAZILIAN INDIVIDUALS WITH SEVERE HAEMOPHILIA A RECEIVING PROPHYLAXIS: RATES OF BLEEDING, FVIII USE, AND QUALITY OF LIFE GG Yamaguti-Hayakawa; PR Villaça; C Lorenzato; MH Cerqueira; LCO Oliveira; ACKVD Nascimento; CBF Dametto; DB Reddy; H Yu; MC Ozelo;